EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Treatment of allergic rhinitis with allergen immunotherapy in children and adolescents—Adherence, rhinitis severity, and asthma onset

Anna M Hedman iD, Cecilia Lundholm, Jon R Konradsen, Åslög Dahl, Maria Ingemansson, Catarina Almqvist iD

Pediatric Allergy and Immunology · 2026-04 · 37 (4)

DOI: 10.1111/pai.70304 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Allergy and Immunology, online erschienen am 08.04.2026. Verfasst von Anna M Hedman und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. Hauptthemen laut MEDLINE: Asthma, Rhinitis, Allergic, Allergens, Sublingual Immunotherapy. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swedish Research Council, the Swedish Heart-Lung Foundation, the Swedish Asthma and Allergy Association Research Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Sublingual immunotherapy (SLIT) has been used to reduce symptoms in allergic rhinitis and to prevent asthma onset. Many studies lack level of adherence and standardized endpoints based on international guidelines.

Objective

We aimed to study the long‐term outcomes of allergic rhinitis severity and asthma onset by adherence of SLIT to grass and birch allergens in children and adolescents with allergic rhinitis.

Methods

In a population‐based register study, we included all children 5–17 years, with initiation of SLIT between 1 July 2006 and 30 June 2022. Allergic rhinitis severity and asthma onset were based on diagnosis and treatment. Adherence was measured for one, two, and 3 years and divided into low, moderate, and high and compared to only one prescription (reference).

Results

7222 children were treated with grass pollen extract and 1184 with birch pollen extract. A significantly lower allergic rhinitis severity was seen in adjusted analyses with odds ratios (OR) of 0.85 (95% confidence interval: 0.72–0.99) and OR 0.81 (0.67–0.96) for the high adherence group (i.e., only one prescription) compared to the reference group in the second and third year respectively after SLIT grass initiation. No statistically significant difference was seen for asthma onset. Estimates for birch SLIT were less conclusive.

Conclusion

We found reduced allergic rhinitis severity with higher adherence and longer treatment duration, particularly for grass SLIT. Shorter follow‐up for birch SLIT and smaller sample size for asthma onset probably influenced our results. The results should encourage clinicians to prescribe SLIT for eligible children and motivate patients to 3‐years full adherence.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AsthmaRhinitis, AllergicAllergensSublingual ImmunotherapyHumansChildAdolescentFemaleMaleChild, PreschoolSeverity of Illness IndexBetulaPollenTreatment OutcomePoaceaeRegistries

Stichwörter der Autor:innen

adherenceallergen immunotherapyallergic rhinitisasthma onsetseverity

Substanzen

Allergens

Autor:innen und Institutionen

  • Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  • Pediatric Allergy and Pulmonology Unit at Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden.
  • Department of Biology and Environmental Sciences, Gothenburg University, Göteborg, Sweden.

ORCID-Profile: Anna M Hedman, Catarina Almqvist

Förderung

  • Swedish Research Council
  • the Swedish Heart-Lung Foundation
  • the Swedish Asthma and Allergy Association Research Fund
  • Region Stockholm
  • the Strategic Research Program in Epidemiology at Karolinska Institutet
  • the Foundation Frimurare Barnhuset in Stockholm
  • Vetenskapsrådet

Zitieren

APA

Hedman, A. M., Lundholm, C., Konradsen, J. R., Dahl, Å., Ingemansson, M., & Almqvist, C. (2026). Treatment of allergic rhinitis with allergen immunotherapy in children and adolescents—Adherence, rhinitis severity, and asthma onset. Pediatric Allergy and Immunology, 37(4). https://doi.org/10.1111/pai.70304

Vancouver

Hedman AM, Lundholm C, Konradsen JR, Dahl Å, Ingemansson M, Almqvist C. Treatment of allergic rhinitis with allergen immunotherapy in children and adolescents—Adherence, rhinitis severity, and asthma onset. Pediatric Allergy and Immunology. 2026;37(4). doi:10.1111/pai.70304

BibTeX
@article{Hedman2026,
  author = {Hedman, Anna M and Lundholm, Cecilia and Konradsen, Jon R and Dahl, Åslög and Ingemansson, Maria and Almqvist, Catarina},
  title = {Treatment of allergic rhinitis with allergen immunotherapy in children and adolescents—Adherence, rhinitis severity, and asthma onset},
  journal = {Pediatric Allergy and Immunology},
  year = {2026},
  volume = {37},
  number = {4},
  doi = {10.1111/pai.70304}
}
Kostenlos starten →